Andrx's Valproate NDA Receives FDA Tentative Approval; Final Approval Pending Expiration of 30-Month Stay or Favorable Resolution of Pending Litigation.
Linked as:
Extract
Andrx's Valproate NDA Receives FDA Tentative Approval; Final Approval Pending Expiration of 30-Month Stay or Favorable Resolution of Pending Litigation.
Business Editors/Health/Medical Writers
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 10, 2004 Andrx Corporation ("Andrx") (Nasdaq:ADRX) today...See the full content of this document
Sponsored links
